Related Experiment Video
Updated: Jun 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Potential of oral combination lipid‑lowering therapy beyond statins: a simulation‑based perspective from the
1Academic Research Organization, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Abstract:
Sequential theoretical addition of ezetimibe and bempedoic acid increased LDL‑C goal achievement and was associated with modeled reductions in MACE. Risk estimates were inferred from LDL‑C lowering in the simulation.Image, graphical abstract.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Bioavailability Enhancement: Drug Permeability Enhancement
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...